Tirzepatide is a dual GLP-1 and GIP receptor agonist, often described as a twincretin. It is a single synthetic peptide designed to activate two incretin receptors simultaneously rather than one
Maintaining Weight Loss Some GLP-1 users who achieve their weight loss goals gradually dial down their dose by tiny amounts in the hope of saving money, building up a stockpile, or even having a more normal appetite without compromising their weight loss success
Dried fruit
While specific requirements can vary by provider, clients are commonly considered good candidates if they meet one of the following criteria: A BMI of 30 or higher (classified as obesity) A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, prediabetes, or sleep apnea In addition, candidates should be in overall stable health, not pregnant or breastfeeding, and not have a personal or family history of certain medical conditions such as medullary thyroid carcinoma or MEN2 (Multiple Endocrine Neoplasia type 2)
Ozempic | European Public Assessment Report
